BDNF and its receptors in human myasthenic thymus: Implications for cell fate in thymic pathology

Journal of Neuroimmunology

Volumn 197, Issue 2, 2008, Pages 128-139

  Berzi, Angela ^a   Ayata, C Korcan ^b   Cavalcante, Paola ^a   Falcone, Chiara ^a   Candiago, Elisabetta ^d   Motta, Teresio ^d   Bernasconi, Pia ^a   Hohlfeld, Reinhard ^b,c   Mantegazza, Renato ^a   Meinl, Edgar ^b,c   Farina, Cinthia ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d OSPEDALI RIUNITI   (Italy)

Author keywords

Germinal center; Hyperplasia; Myasthenia gravis; Neurotrophic factor; Thymoma; Thymus

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; NEUROTROPHIN RECEPTOR P75;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL DEATH; CELL FATE; CELL POPULATION; CELL PROLIFERATION; EPITHELIUM CELL; GERMINAL CENTER; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPLASIA; IMMUNOCOMPETENT CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MYASTHENIA GRAVIS; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYMOCYTE; THYMOMA; THYMUS;

ADULT; AGED; ANTIGENS, CD; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASPASE 3; CELL DEATH; CELL DIFFERENTIATION; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; HUMANS; KERATINS; KI-67 ANTIGEN; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; RECEPTORS, NERVE GROWTH FACTOR; THYMUS EXTRACTS; THYMUS GLAND;

EID: 46649097992     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2008.04.019     Document Type: Article

References (28)

1. Besser M., and Wank R. Cutting edge: clonally restricted production of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3 mRNA by human immune cells and Th1/Th2-polarized expression of their receptors. J. Immunol. 162 (1999) 6303-6306
2. Bibel M., and Barde Y.A. Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev. 14 (2000) 2919-2937
3. Conti-Fine B.M., Milani M., and Kaminski H.J. Myasthenia gravis: past, present, and future. J. Clin. Invest. 116 (2006) 2843-2854
4. Dechant G., and Barde Y.A. The neurotrophin receptor p75(NTR): novel functions and implications for diseases of the nervous system. Nat. Neurosci. 5 (2002) 1131-1136
5. Douma S., Van Laar T., Zevenhoven J., Meuwissen R., Van Garderen E., and Peeper D.S. Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB. Nature 430 (2004) 1034-1039
6. Garcia-Suarez O., Hannestad J., Esteban I., Martinez del Valle M., Naves F.J., and Vega J.A. Neurotrophin receptor-like protein immunoreactivity in human lymph nodes. Anat. Rec. 249 (1997) 226-232
7. Garcia-Suarez O., Blanco-Gelaz M.A., Lopez M.L., Germana A., Cabo R., Diaz-Esnal B., Silos-Santiago I., Ciriaco E., and Vega J.A. Massive lymphocyte apoptosis in the thymus of functionally deficient TrkB mice. J. Neuroimmunol. 129 (2002) 25-34
8. Hannestad J., Levanti M.B., and Vega J.A. Distribution of neurotrophin receptors in human palatine tonsils: an immunohistochemical study. J. Neuroimmunol. 58 (1995) 131-137
9. He X.L., and Garcia K.C. Structure of nerve growth factor complexed with the shared neurotrophin receptor p75. Science 304 (2004) 870-875
10. Jaretzki III A., Barohn R.J., Ernstoff R.M., Kaminski H.J., Keesey J.C., Penn A.S., and Sanders D.B. Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology 55 (2000) 16-23
11. Kerschensteiner M., Gallmeier E., Behrens L., Leal V.V., Misgeld T., Klinkert W.E., Kolbeck R., Hoppe E., Oropeza-Wekerle R.L., Bartke I., Stadelmann C., Lassmann H., Wekerle H., and Hohlfeld R. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?. J. Exp. Med. 189 (1999) 865-870
12. Ketterer K., Rao S., Friess H., Weiss J., Buchler M.W., and Korc M. Reverse transcription-PCR analysis of laser-captured cells points to potential paracrine and autocrine actions of neurotrophins in pancreatic cancer. Clin. Cancer Res. 9 (2003) 5127-5136
13. Kim D.J., Yang W.I., Kim S.H., Park I.K., and Chung K.Y. Expression of neurotrophin receptors in surgically resected thymic epithelial tumors. Eur. J. Cardiothorac. Surg. 28 (2005) 611-616
14. Labouyrie E., Parrens M., de Mascarel A., Bloch B., and Merlio J.P. Distribution of NGF receptors in normal and pathologic human lymphoid tissues. J. Neuroimmunol. 77 (1997) 161-173
15. Labouyrie E., Dubus P., Groppi A., Mahon F.X., Ferrer J., Parrens M., Reiffers J., de Mascarel A., and Merlio J.P. Expression of neurotrophins and their receptors in human bone marrow. Am. J. Pathol. 154 (1999) 405-415
16. Maeda K., Matsuda M., Suzuki H., and Saitoh H.A. Immunohistochemical recognition of human follicular dendritic cells (FDCs) in routinely processed paraffin sections. J. Histochem. Cytochem. 50 (2002) 1475-1486
17. Marinova T.T., Velikova K.K., Petrov D.B., Kutev N.S., Stankulov I.S., Chaldakov G.N., Triaca V., Manni L., and Aloe L. Structural and ultrastructural localization of NGF and NGF receptors in the thymus of subjects affected by myasthenia gravis. Autoimmunity 37 (2004) 587-592
18. Maroder M., Bellavia D., Meco D., Napolitano M., Stigliano A., Alesse E., Vacca A., Giannini G., Frati L., Gulino A., and Screpanti I. Expression of trKB neurotrophin receptor during T cell development. Role of brain derived neurotrophic factor in immature thymocyte survival. J. Immunol. 157 (1996) 2864-2872
19. Marx A., Muller-Hermelink H.K., and Strobel P. The role of thymomas in the development of myasthenia gravis. Ann. N. Y. Acad. Sci. 998 (2003) 223-236
20. Meinl E., Klinkert W.E., and Wekerle H. The thymus in myasthenia gravis. Changes typical for the human disease are absent in experimental autoimmune myasthenia gravis of the Lewis rat. Am. J. Pathol. 139 (1991) 995-1008
21. Parrens M., Labouyrie E., Groppi A., Dubus P., Carles D., Velly J.F., de Mascarel A., and Merlio J.P. Expression of NGF receptors in normal and pathological human thymus. J. Neuroimmunol. 85 (1998) 11-21
22. Rosai J., and Sobin L.H. Histological Typing of Tumours of the Thymus. World Health Organization International Histological Classification of Tumours (1999), Springer-Verlag, New York, NY
23. Schuhmann B., Dietrich A., Sel S., Hahn C., Klingenspor M., Lommatzsch M., Gudermann T., Braun A., Renz H., and Nockher W.A. A role for brain-derived neurotrophic factor in B cell development. J. Neuroimmunol. 163 (2005) 15-23
24. Sims G.P., Shiono H., Willcox N., and Stott D.I. Somatic hypermutation and selection of B cells in thymic germinal centers responding to acetylcholine receptor in myasthenia gravis. J. Immunol. 167 (2001) 1935-1944
25. Stoilov P., Castren E., and Stamm S. Analysis of the human TrkB gene genomic organization reveals novel TrkB isoforms, unusual gene length, and splicing mechanism. Biochem. Biophys. Res. Commun. 290 (2002) 1054-1065
26. Takahama Y. Journey through the thymus: stromal guides for T-cell development and selection. Nat. Rev. Immunol. 6 (2006) 127-135
27. Timmusk T., Palm K., Lendahl U., and Metsis M. Brain-derived neurotrophic factor expression in vivo is under the control of neuron-restrictive silencer element. J. Biol. Chem. 274 (1999) 1078-1084
28. Vega J.A., Garcia-Suarez O., Hannestad J., Perez-Perez M., and Germana A. Neurotrophins and the immune system. J. Anat. 203 (2003) 1-19